Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 48 (2014): Issue 1 (March 2014)
Open Access
Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey
Marina Hodolic
Marina Hodolic
,
Laure Michaud
Laure Michaud
,
Virginie Huchet
Virginie Huchet
,
Sona Balogova
Sona Balogova
,
Valérie Nataf
Valérie Nataf
,
Khaldoun Kerrou
Khaldoun Kerrou
,
Marika Vereb
Marika Vereb
,
Jure Fettich
Jure Fettich
and
Jean-Noël Talbot
Jean-Noël Talbot
| Jan 22, 2014
Radiology and Oncology
Volume 48 (2014): Issue 1 (March 2014)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jan 22, 2014
Page range:
20 - 28
DOI:
https://doi.org/10.2478/raon-2013-0049
Keywords
prostate cancer
,
PET/CT
,
fluorocholine (FCH)
,
fluoride(18F)
,
bone scintigraphy
,
indication of imaging
This content is open access.
Marina Hodolic
Department for nuclear medicine, University Medical Centre, Ljubljana, Slovenia
Laure Michaud
Médecine nucléaire, Hôpital Tenon, AP-HP, Paris, France
Université Pierre et Marie Curie, Paris, France
Virginie Huchet
Médecine nucléaire, Hôpital Tenon, AP-HP, Paris, France
Sona Balogova
Médecine nucléaire, Hôpital Tenon, AP-HP, Paris, France
Comenius University, Bratislava, Slovakia
Valérie Nataf
Radiopharmacie, Hôpital Tenon, AP-HP, Paris, France
Khaldoun Kerrou
Médecine nucléaire, Hôpital Tenon, AP-HP, Paris, France
Marika Vereb
Nuklearmedizin, Kassel Klinikum, Kassel, Germany
Jure Fettich
Department for nuclear medicine, University Medical Centre, Ljubljana, Slovenia
Jean-Noël Talbot
Médecine nucléaire, Hôpital Tenon, AP-HP, Paris, France
Université Pierre et Marie Curie, Paris, France